文献速递流行病学与生物统计临床试验与 GCP

爱尔兰健康研究随机对照试验的质量、范围与报告标准:一项观察性研究

Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study.
PubMed 文献 · Trials · 2020-06-08

结果显示RCT数量逐年增加,但注册率和报告规范引用率仍不理想,2013-2018年发表的RCT中仅47%提供注册号,31%引用报告指南。

要点

  • 1968至2018年爱尔兰RCT数量持续增长,共752项发表于745篇论文。
  • 2005年强制注册后发表的418项RCT中,仅32%提供注册号;2013-2018年升至47%。
  • 1996年CONSORT声明后,16%的RCT引用报告指南;2013-2018年升至31%。

核心结论

  • 爱尔兰RCT数量、注册数和报告指南引用率随时间稳步增加,但报告质量仍不理想。

研究设计与样本

  • 共纳入1968至2018年间发表的752项RCT(745篇论文),由一名作者团队成员完成筛选、数据提取和质量评价。

主要发现

  • RCT数量自1968年以来逐年稳步增加,参与者数量范围为2-8628。
  • 大多数RCT为平行设计(86%),归类为治疗评估。
  • 2005年ICMJE强制注册后发表的418项RCT中,32%(n=134)提供注册号;2013-2018年发表的232项中增至47%。
  • 自1996年CONSORT声明发表以来,16%的RCT引用标准化报告指南;2013-2018年发表的研究中增至31%。
  • 7%(n=53)的研究引用已发表的研究方案;2013-2018年发表的研究中增至20%。

关键数值与推荐

  • 纳入标准:RCT的≥80%参与者从爱尔兰共和国招募,干预目标为患者、提供者或政策制定者。
  • 排除标准:未提及。

临床怎么用

  • 研究人员、资助者和期刊编辑应持续关注提高RCT报告质量,并审视可避免的研究投资浪费。

局限性

  • 筛查、数据提取和质量评价由单一作者完成,可能存在偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite efforts to improve the accuracy and transparency of the design, conduct, and reporting of randomised controlled trials (RCTs), deficiencies remain. Such deficiencies contribute to significant, avoidable waste of health research investment and impede reproducibility. This study aimed to synthesise and critically analyse changes over time in the conduct and reporting of internationally published evidence on patient and/or population health-oriented RCTs conducted in one country. METHODS: This observational study drew on systematic review methods. We searched six databases for published RCTs (database inception to December 2018) where ≥ 80% of participants were recruited in the Republic of Ireland. RCTs of interventions targeted at patients, providers and/or policy makers intended to improve health, healthcare or health research were included. For each study, screening, data extraction and methodological quality appraisal were conducted by one member of the author team. RESULTS: From 17,560 titles and abstracts, 752 unique RCTs were published in 745 papers between 1968 and 2018, with a steady year-on-year increase since 1968. The number of participants was in the range of 2-8628. The majority were parallel design (86%) and classified as treatment evaluation. Of the 418 RCTs published since the introduction of mandatory clinical trial registration by the International Committee of Medical Journal Editors in 2005, 32% (n = 134) provided a trial registration number. This increased to 47% when taking studies published between 2013 and 2018 (n = 232). Since the 1996 publication of the CONSORT statement, 16% of included RCTs made specific reference to a standardised reporting guideline and this increased to 31% for more recent studies published between 2013 and 2018. Overall, 7% (n = 53) of studies referred to a published study protocol, increasing to 20% for studies published between 2013 and 2018. CONCLUSION: Evidence from this single-country study of RCTs published in the international literature suggests that both the number overall, the number registered and the number referencing reporting guidelines have increased steadily over time. Despite widespread endorsement of reporting standards, reporting of RCTs remains suboptimal in domains such as compliance with the CONSORT statement and prospective trial registration. Researchers, funders and journal editors, nationally and internationally, should continue to focus on improving reporting and examining avoidable waste of health research investment.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Clyne B, Boland F, Murphy N, et al. Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study. Trials. 2020. PMID: 32513240. doi:10.1186/s13063-020-04396-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。